SUBSCRIBE
SUBSCRIBE
News   FDA

Allergan Inc. Eye Drug Wins EU OK For Fluid Buildup

July 29, 2010 | 
1 min read
NEW YORK, July 28 (Reuters) - Allergan Inc (AGN.N) on Wednesday said its drug Ozurdex has become the first drug in Europe approved to treat a eyesight-endangering condition in which fluid builds up in the retina because of a clogged vein.
FDA Approvals Europe
MORE ON THIS TOPIC
Traffic sign: Right U-turn sign on cement pole beside the rural road with sunset or sunrise background, copy space.
Government
FDA to Rehire Some Travel Staff as Lapses Begin to Show: AP
May 2, 2025
 · 
2 min read
 · 
Tristan Manalac
Vaccine and syringe injection. Doctor hand with syringe. Vaccination of people for prevention, immunization and treatment from virus infection. Medicine, flu shot, test with needle. Vector
Policy
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
May 1, 2025
 · 
3 min read
 · 
Heather McKenzie
Minimal Clip Art Collage. Pop Vector Design Composition with bright bold geometric shapes, halftone objects for ad, animation etc
Approvals
J&J Steps Into Crowded Myasthenia Gravis Market With FDA Nod
May 1, 2025
 · 
2 min read
 · 
Tristan Manalac
complex business management or organization, distraction and complicated business process
Government
FDA Misses Another Deadline Amid Staff Exodus, Structural Disruptions
May 1, 2025
 · 
2 min read
 · 
Tristan Manalac